Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

被引:0
|
作者
Michael Croft
机构
[1] La Jolla Institute for Allergy and Immunology,Division of Molecular Immunology
来源
Nature Reviews Immunology | 2003年 / 3卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Five interactions between the tumour-necrosis factor receptor (TNFR)–TNF family members have emerged as positive regulators of T cells: OX40–OX40 ligand (OX40L), 4-1BB–4-1BBL, CD27–CD70, herpes-virus entry mediator (HVEM)–LIGHT and CD30–CD30L. The co-stimulatory TNFR-family members are mainly expressed by T cells and their ligands by antigen-presenting cells (APCs).There are two patterns of expression of the co-stimulatory TNFR-family molecules: constitutive (such as CD27 and HVEM) and inducible (such as OX40, 4-1BB and CD30). All can potentially participate in T-cell responses either at the time of T-cell activation or within the first few days of activation.In vitro and in vivo data indicate that HVEM–LIGHT interactions promote the early activation and clonal expansion of T cells, CD27–CD70 might also help to maintain early proliferation, OX40–OX40L and 4-1BB–4-1BBL and CD30–CD30L seem to regulate later expansion of T-cell numbers at the peak of the response.Co-stimulatory TNFR-family signalling seems to regulate T-cell division, survival and effector function by activating nuclear factor-κB (NF-κB), JNK pathways and phosphatidylinositol 3-kinase (PI3K)–protein kinase B (PKB) pathways.It is not clear whether all the TNFR-family molecules are required to function together (simultaneously or sequentially) to regulate a response or whether different responses require different co-stimulatory interactions.Survival signals from TNFR-family members might be crucial for secondary responses and the maintenance of T-cell memory.Blocking co-stimulatory TNF family members might be of benefit in inflammatory and autoimmune diseases and in preventing transplant rejection, whereas promoting these interactions might enhance antitumour immunity.
引用
收藏
页码:609 / 620
页数:11
相关论文
共 50 条
  • [41] Segregation of co-stimulatory components into specific T cell surface lipid rafts
    Millán, J
    Qaidi, M
    Alonso, MA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (02) : 467 - 473
  • [42] GITR/GITRL: More than an effector T cell co-stimulatory system
    Nocentini, Giuseppe
    Ronchetti, Simona
    Cuzzocrea, Salvatore
    Riccardi, Carlo
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (05) : 1165 - 1169
  • [43] Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation
    Rambaldi, Benedetta
    Kim, Haesook T.
    Arihara, Yohei
    Asano, Takeru
    Reynolds, Carol
    Manter, Mariah
    Halpern, Max
    Weber, Augustine
    Koreth, John
    Cutler, Corey
    Gooptu, Mahasweta
    Nikiforow, Sarah
    Ho, Vincent T.
    Antin, Joseph H.
    Romee, Rizwan
    Ampudia, Jeanette
    Ng, Cherie
    Connelly, Stephen
    Soiffer, Robert J.
    Ritz, Jerome
    HAEMATOLOGICA, 2022, 107 (11) : 2617 - 2629
  • [45] Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantation
    Rambaldi, Benedetta
    Kim, Haesook T.
    Arihara, Yohei
    Asano, Takeru
    Reynolds, Carol
    Manter, Mariah
    Halpern, Max
    Weber, Augustine
    Koreth, John
    Cutler, Corey
    Gooptu, Mahasweta
    Nikiforow, Sarah
    Ho, Vincent T.
    Antin, Joseph H.
    Romee, Rizwan
    Ampudia, Jeanette
    Ng, Cherie
    Connelly, Stephen
    Soiffer, Robert J.
    Ritz, Jerome
    HAEMATOLOGICA, 2022, 107 : 2617 - 2629
  • [46] Vector-based delivery of tumor-associated antigens and T-cell co-stimulatory molecules in the induction of immune responses and anti-tumor immunity
    Hodge, JW
    Grosenbach, DW
    Schlom, J
    CANCER DETECTION AND PREVENTION, 2002, 26 (04): : 275 - 291
  • [47] EFFECTOR PHASE ABNORMALITIES OF CELL MEDIATED IMMUNITY IN FAMILY MEMBERS OF A CHILD WITH HEREDITARY T-CELL IMMUNODEFICIENCY
    COHEN, F
    LIGHTBODY, JJ
    PEDIATRIC RESEARCH, 1973, 7 (04) : 363 - 363
  • [48] A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
    Hoogi, Shiran
    Eisenberg, Vasyl
    Mayer, Shimrit
    Shamul, Astar
    Barliya, Tilda
    Cohen, Cyrille J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01): : 243
  • [49] Effect of Drotrecogin alfa (activated) on MHC-class II and T-cell co-stimulatory molecules on monocytes in vitro
    Baderschneider, M.
    Brueckmann, M.
    Steinkrueger, S.
    Rossaint, R.
    Rink, L.
    de Rossi, L.
    INFECTION, 2005, 33 : 22 - 22
  • [50] Changes in T-cell associated cytokines and co-stimulatory molecule expression in a Hu/scid model of skin allograft rejection
    Carroll, JM
    Gunn, J
    O'Hara, RM
    FASEB JOURNAL, 2000, 14 (06): : A1069 - A1069